Introduction
Hyperthyroxinaemia in euthyroid patients is most commonly due to an elevation of thyroxine-binding globulin (TBG). A rare cause is familial dysalbuminaemic hyperthyroxinaemia (FDH), an autosomal dominant syndrome in which euthyroid patients have elevated serum total thyroxine (1'4) and free thyroxine index (FTI) but normal total triiodothyronine (1'3)1.2, These findings are due to an abnormal serum albumin with increased affinity for 1'4 but not 1'3 3 " 5. Rarer causes of euthyroid hyperthyroxinaemia include excessive binding by T4-binding prealbumin (TBPA)6 and artefactual serum 1'4 elevations due to circulating antibodies to 1'4 7 • Such euthyroid patients and their affected relatives may be mistakenly diagnosed as thyrotoxic on the basis of routine 1'4 assays. It is important that their euthyroid status be established by careful clinical and laboratory investigations to prevent inappropriate treatment. FDH can be screened for by a simple test to detect the presence of the abnormal serum albumin 1.8. We report studies in 4 unrelated patients and one family in which3members have FDH. Wealso present results in 2 patients with autoantibodies to 1'4.
Methods
Serum total 1'4, total 1'3, 1'BG and thyroidstimulating hormone (TSH) (International Reference Preparation 68/38)were measured by in.house double antibody radioimmunoassay. The F1'I was 0.01 of the product of total 1'4 and 1'3 Sephadex uptake (T3SU) values", Serum free 1'4 and free 1'3 were measured by equilibrium dialysis10, TBPA by an immunoelectrophoretic method II, and albumin by bromocresol green (Technicon SMAC). Anti-T4 and anti-T3 antibodies were measured by the nonspecific binding of 125 1_1'4 or 125 1_1'3 in barbitone buffer in the presence of excess 8-aniline-1-naphthalene sulphonic acid followed by polyethylene glycol separation. Thyrotrophin-releasing hormone (TRH) (Roche) was given intravenously at a dose of 200mg, and blood collected at 0 and 20 minutes was assayed for TSH to determine response to TRH.
Screening for excess 1'4 binding by albumin and TBPA was performed according to StockigtI. Sephadex uptake of 125 1_1'4 (T4SU) by the test serum (final dilution of1:100)in phosphate buffer (67 mmol/l, pH 7.4) is measured in the presence of 3 different unlabelled 1'4 concentrations, namely (a) basal sample with no 1'4 added; (b) 1'4 added to a final concentration of5 x 10-8 mol/l; and (c)1'4 added to a final concentration of 10-6 mol/l. The T4SU is expressed as a percentage of a normal reference pool, and percentage increments between basal and 1'4 loaded T4SU are calculated ( Table 1 ).
In serum from normal subjects, the addition of the unlabelled 1'4 load displaces 125 1_1'4 from serum proteins on to the Sephadex so that the normal mean T4SU of 103% increases to means of 127% and 208% at 5 x 10-8 and 10-6 mol/I 1'4 respectively. Samples with raised or low TBG and from hyperthyroid and hypothyroid patients give similar results. In FDH, binding by the abnormal albumin is sufficiently excessive to bind both higher 1'4 concentrations, so that T4SU increases are negligible ( Table 1 ). In patients with prealbumin hyperthyroxinaemia (PAH), it has been calculated that the 1'4 binding capacity of the abnormal prealbumin would be exceeded by the 10-6 mol/l 1'4 load but not the 5 x 10-8 mol/l T410ad l .
Clinical studies A 32-year-old male (GC) with treated Hodgkin's disease in remission presented with attacks of anxiety, flushing and palpitations but showed no signs of thyrotoxicosis, Graves' disease or goitre. Great aunts on both sides of his family had a history of 'thyroid problems'. Because of repeated high serum 1'4 with normal serum 1'3, he was referred for a TRH test. Elevated serum 1'4 and FTI with normal 1'3 were confirmed on this occasion and in three further samples collected over the next 6 months. The mean values, with reference ranges in brackets, were as follows: 1'4 202nmol/I (74-152); FTI 191 (78-146); total 1'3 1.9 nmol/l (1.2-2.5). A brisk response to TRH (basal TSH 2.6 mUll rising to 31 mUll at 20min) excluded hyperthyroidism. Other thyroid function tests, including free 1'3 and free 1'4measured by equilibrium dialysis, TBG and TBPA were normal, as was serum albumin. Antibodies to T3, T4, thyroglobulin and thyroid microsomes were absent. The patient remained clinically euthyroid during the 6 months of observation.
Other members of his family were studied. The mother (RC) and sister (MS) had elevated serum T4 and FTI with normal T3 and TBG levels. The father (CC), two brothers (BC and PC) and the daughter of BC showed no abnormalities.
As the results of affected members were consistent with FDH, all sera were tested by the T4SU test. Serum from GC, RC and MS were positive for FDH, whereas the others were negative ( Table 2) . Although the data confirm the familial nature of the syndrome, further investigation of the mode of inheritance was not possible as both GC and his sister, MS, have no children. All members of the family and their physicians were informed of these findings to prevent further unnecessary testing of the affected individuals and the possible misdiagnosis of thyrotoxicosis.
Recently, 6 additional patients were referred from other hospitals in Adelaide with unexplained elevated serum T4 without clinical features ofthyrotoxicosis (Table 3 ). Four unrelated patients were shown to have FDH by the T4SU test; it is not possible Journal of the Royal Society of Medicine Volume80 December1987 to study families ofthese patients. Two other patients were negative for FDH, but had antibodies to T4.
Discussion
Euthyroid hyperthyroxinaemia is defined as any condition in which serum T4 is increased in the absence of thyrotoxicosis. The many causes included TBG excess, FDH, antibodies to T4, peripheral resistance to T4, PAH, acute psychiatric illness and the administration of certain drugs.
TBG excess, either inherited or acquired, is the commonest cause of hyperthyroxinaemia. In these situations, total T4, total T3 and TBG are elevated. Calculated indices such as FTI frequently do not correct for the increased thyroid hormone levels, but free T4 and free T3 by equilibrium dialysis would.
Antibodies to T4 or T3 are usually associated with autoimmune thyroid disease and may cause apparent increase of T4 or T3 as a result of assay artefacts. False elevation of total serum T4 was particularly notable in patient B but less obvious in patient A (Table 3) . A euthyroid patient not included in this study had normal T4 and FTI, but T3 antibodies falsely elevated total serum T3levels to 7.9 nmol/l. FDH is an important cause of euthyroid hyperthyroxinaemia to recognize, as other members of the family may be affected. It is due to the presence of an abnormal albumin with increased affinity for T4 but little or no increased affinity for T3 1 -5. Consequently, serum T3 and T3SU are normal but FTI, calculated from T4 and T3SU, is elevated, suggesting the erroneous diagnosis of thyrotoxicosis. Free T4 measured by equilibrium dialysis is normal and would be helpful but is not available routinely. When FDH is suspected it is essential to screen with T4SU and exclude hyperthyroidism with a TRH test.
In PAH 6 , laboratory findings are similar to those found in FDH but are due to a variant TBPA which can be distinguished from FDH with the T4SU test. We have not detected this anomaly in any patient referred to our laboratory. More recently, other variants of both albumin and TBPA have been described that also bind T3 and reverse-T3 with increased affinit y I 2. 13 .
We encountered the 7 FDH patients and the two with T4 antibodies over a period of approximately 12 months in a population pool of about one million. The prevalence in this population is likely to be much higher than indicated from these figures and increasing awareness may lead to more cases being recognized. Inappropriate treatment of such euthyroid patients, sometimes resulting in permanent effects, has been reported 4.8.14, as also has the coexistence of thyroid disease with FDH 8. Methods of detecting the common TBG elevations and the less common causes of T4 elevations in euthyroid subjects are well documented and relatively simpleI,8,14, and clinicians and clinical biochemists should be prepared to use such tests as well as TRH testing when unexpectedly high serum T4 is encountered.
